Healthcare -
Biotechnology - NASDAQ - US
$ 19.07
-7.43 %
$ 3.24 B
Market Cap
-7.28
P/E
IMVT - CASH FROM OPERATIONS
Cash from Operations IMVT - Immunovant, Inc.
-214 M
LAST VALUE
-42.09%
2 YEAR CAGR
-49.65%
5 YEAR CAGR
0.00%
10 YEAR CAGR